Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) T.ATE


Primary Symbol: ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by Pronorvistaon Nov 01, 2023 9:12pm
210 Views
Post# 35712555

ATE

ATE

Market By Price

Price Total Volume Value
0.940 500 $470
0.890 11,000 $9,790
0.880 4,400 $3,872
0.850 28,000 $23,800
0.840 1,000 $840
0.830 6,200 $5,146
0.800 22,000 $17,600
0.780 8,000 $6,240
0.770 6,500 $5,005
0.760 6,000 $4,560
0.750 15,000 $11,250
0.740 9,500 $7,030
0.730 5,000 $3,650
0.720 8,500 $6,120
0.710 5,000 $3,550
0.700 42,000 $29,398
0.690 10,500 $7,244
0.680 12,500 $8,500
0.670 12,000 $8,040
0.660 39,500 $26,070
 

<< Previous
Bullboard Posts
Next >>